Key facts
- It has raised $2.1M; the latest was Later Stage VC in Dec 2025.
- Notable investors include International Blockchain Consulting, FasterCapital, Google Cloud Platform.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Biokript
- ·The full record, as it builds
Funding rounds
No funding rounds for Biokript are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Biokript
Operator of a hybrid cryptocurrency trading platform designed for secure digital asset exchange. The company's platform combines centralized speed with decentralized self-custody, featuring patented hybrid architecture, AI-driven bots, anti-rug safeguards, on-chain stop-loss, and profit-sharing, enabling traders to access transparent, high-performance trading with shared financial benefits.
- Sector
- Financial Services
- HQ
- Glendale, AZ, United States
- Founded
- 2017
- Employees
- 11
- Website
- biokript.com/
- Ownership
- Privately Held (backing)
Biokript doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Biokript shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Biokript in its N-PORT filings yet. We sweep new filings monthly.